AR50 High purity |Best quality High purity | High-quality products|China
TDS
681006-28-0
Pharmaceutical Grade
99.87%
HONGKONG
Customization Available
50mg*10vials/box
2026-10-30
Retatrutide,Tirzepatide,GLOW,KLOW80,NAD+,TB500
-
Product Description
-
Seller Information
-
History Price
-
DescriptionCertificates
-
TDS
Basic Info-
Product Name:
AICAR (phosphate)
Other Name:AICAR (Acadesine) phosphate;AICAR (phosphate);5-Amino-1-ribosylimidazole-4-carboxamide phosphate;AICAR phosphate, >98%;AICA Riboside phosphate);AICAR phosphate (Acadesine phosphate;Acadesine phosphate;ACADESINE PHOSPHATE;AICA RIBOSIDE PHOSPHATE
CAS No.:681006-28-0
Molecular Formula:C9H17N4O9P
Molecular Weight:356.23
Color/Form:White to off-white
Categories:
Characteristics-
Critical Temperature & Pressure:
Store at -20°C
Research-
Class:
Dual agonist — GIPR, GLP-1R
Status:FDA-approved (Mounjaro / Zepbound)
Mechanism:Dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. A 39-amino-acid modified peptide with a C20 fatty diacid moiety that enables albumin binding for extended half-life (~5 days). Selectively activates both GIPR and GLP-1R signaling pathways.
EC50 (Human GLP1R):0.934 nM
EC50 (Human GIPR):0.0224 nM
Source:Frias JP, et al. N Engl J Med. 2021;385(6):503-515.DOI
Clinical Development:NCT03954834; NCT03987919; NCT03882970; NCT03730662; NCT04039503
FDA:Mounjaro, Zepbound (approved 2022-05-13)
References-
ChEMBL:DrugBank:KEGG DRUG:PubChem:Disclaimer:
Tirzepatide is approved as a prescription medicine (Mounjaro, Zepbound) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Retatrutide,Tirzepatide,GLOW,KLOW80,NAD+,TB500
-
Location:
Room 11B, Building 0056, No. 81-1 Nonglinxia Road, Yuexiu District, Guangzhou City, Guangdong Province
-
Payment Terms:
100% TT in advance
-
Average lead Time:
7
-
Total Annual Revenue:
$1 million-$2.5 million
-
Total Employees:
5-10
-
Year of Establishment:
2026
-
-
Weekly Price
The chart shows the price trend of the product in the past 12 months.
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product